Teladoc Health (NYSE:TDOC) Insider Fernando Rodrigues Sells 5,677 Shares

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 5,677 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $43,315.51. Following the completion of the sale, the insider directly owned 9,572 shares of the company’s stock, valued at $73,034.36. This trade represents a 37.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Teladoc Health Price Performance

Shares of Teladoc Health stock opened at $7.08 on Thursday. Teladoc Health, Inc. has a 52-week low of $4.40 and a 52-week high of $9.77. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -7.30 and a beta of 2.14. The company has a fifty day moving average of $6.13 and a 200-day moving average of $6.21. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The business had revenue of $613.85 million during the quarter, compared to analysts’ expectations of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. Teladoc Health’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same period last year, the company posted ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Equities research analysts expect that Teladoc Health, Inc. will post -0.91 EPS for the current year.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC increased its position in shares of Teladoc Health by 694.5% during the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after buying an additional 4,945 shares during the period. PNC Financial Services Group Inc. lifted its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the period. IFP Advisors Inc lifted its position in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd lifted its position in Teladoc Health by 101.1% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 2,425 shares during the period. Finally, International Assets Investment Management LLC purchased a new position in Teladoc Health during the 4th quarter valued at about $45,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Bank of America raised shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price target for the company in a research report on Thursday, February 26th. Leerink Partners dropped their price target on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a research report on Thursday, February 26th. Oppenheimer dropped their price target on shares of Teladoc Health from $12.00 to $7.00 and set an “outperform” rating for the company in a research report on Tuesday, March 3rd. Weiss Ratings raised shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, May 22nd. Finally, Piper Sandler reissued an “overweight” rating and set a $9.00 price target (down from $12.00) on shares of Teladoc Health in a research report on Thursday, February 26th. Five equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $7.43.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.